BSX vs STEP · P/E 20, rev $16.75B vs rev $1.99B
Boston Scientific Corp (BSX) versus Stepstone Group Inc (STEP) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Stepstone Group Inc (STEP) is a asset management company listed on NASDAQ.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported STEP revenue for 2026-03-31 was $1.99B. Net income was -$535.8M. Revenue was up 69.7% from 2025-03-31 to 2026-03-31. STEP currently screens at market cap $5.78B.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. STEP currently screens at market cap $5.78B.
Not investment advice. Open the BSX and STEP stock pages for the full models.
Not investment advice.